Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, August 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Product Launches at Lab Innovations 2013
Tuesday, October 01, 2013
Over 40% of exhibitors at Lab Innovations 2013 are using the show to launch new technologies and services into the UK.

Mercury Emissions Monitor Draws Crowds in Edinburgh
Monday, September 23, 2013
New continuous mercury monitoring system from Gasmet.

ELGA Process Water Provides the Right Quality for Nuclear Research
Friday, September 20, 2013
Company supplies a laboratory water system to Dalton Cumbrian Facility.

Hamamatsu Photonics New Upgraded High Performance MPPC Detectors
Friday, September 20, 2013
New detectors utilize a Geiger-mode pixelated avalanche photodiode structure.

Agilent to Demonstrate Mobile Forensics Laboratory at Criminalistica 2013
Monday, September 09, 2013
Criminalistics conference in Brazil will take place on 14-19 September.

MicroAqua: A 12 Party Consortium Drives the Development of a Microarray
Monday, September 09, 2013
Scienion technology used for multiparameter testing to enable biohazard detection in water.

Agilent Technologies Launches New Triple Quadrupole GC/MS
Thursday, September 05, 2013
Company builds on 45 years of leadership and innovation to create industry's best, most reliable GC/MS system for trace analysis.

Thermo Fisher Scientific to Resell IonSense ID-CUBE Ion Source
Thursday, September 05, 2013
ID-CUBE with Orbitrap LC-MS systems simplify food, environmental, pharmaceutical and forensic analyses.

Food Safety Testing, Environmental Analysis and Forensic Toxicology Made Simple with New AB SCIEX Software
Tuesday, September 03, 2013
MasterView™ Software improves ability to identify known and unknown compounds in automated process.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 361
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv